Clinical Trials Sponsored by Jacqueline de Melo Barcelar
Total 1 results
-
Jacqueline de Melo BarcelarCompleted
Sponsors and Collaborators
- Janssen (China) Research & Development Center
- Nestlé Health Science Belgium
- Hazelden Betty Ford Foundation
- Physip S.A
- UZ Leuven, campus Pellenberg (Belgium)
- The Fred Hollows Foundation, Australia
- Advanced Life Solutions
- JMI Laboratories
- Fogarty International Center of the National Institute of Health
- Markham Stouffville Hospital
- Prof. Jacques SCHRENZEL
- Stannah Stairlifts
- Hospital Samaritano Paulista
- Dr. Praveen B.H
- Pedro Gamito
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- IN-JET APS
- Familien Hede Nielsens Fond
- Custom Pharmaceuticals Limited
- View Full List
Medical Conditions
- Chlamydophila Infections
- Skull Base Neoplasms
- Endocarditis Infective
- Painless Hysteroscopy
- Psoriasis, Arthritic
- Fracture Dislocation of Cervical Spine
- Predictors of Atrial Fibrillation Recurrences
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Tay-Sachs Disease Ganglioside
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Closure; Foramen Ovale
- Multisystem Proteinopathy
- Ewing's Family Tumors
- Pulmonary Adenocarcinoma
- Epidemic Hemorrhagic Fever
- Childhood Langerhans Cell Histiocytosis
- Fetus or Neonate Affected by External Version Before Labor
- Spine Surgeries
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Gullian Barre Syndrome
- View Full List
Drug Interventions
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Azelastine hydrochloride (BAYR9258)
- Adapalene Gel 0.3%
- Qingkailing injection 40 ml
- High dose pantoprazole infusion
- Esomeprazole 40mg before
- Redifferentiation with retinoid acid
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Glimepiride
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Estradiol+Drospirenone
- Chemotherapeutic Agent
- Semapimod
- EFV +TVA
- Adriamycin
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Vehicle
- Cereport
- Neihulizumab
- Palliative care group first-line scheme
- View Full List
CROs by country
- Contract Research Organizations in Cyprus
- Contract Research Organizations in France
- Contract Research Organizations in Georgia
- Contract Research Organizations in India
- Contract Research Organizations in Kenya
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Peru
- Contract Research Organizations in Portugal
- Contract Research Organizations in Taiwan
- Contract Research Organizations in United States
- CRO list by country